keyword
https://read.qxmd.com/read/38609392/early-deficits-in-an-in-vitro-striatal-microcircuit-model-carrying-the-parkinson-s-gba-n370s-mutation
#21
JOURNAL ARTICLE
Quyen B Do, Humaira Noor, Ricardo Marquez-Gomez, Kaitlyn M L Cramb, Bryan Ng, Ajantha Abbey, Naroa Ibarra-Aizpurua, Maria Claudia Caiazza, Parnaz Sharifi, Charmaine Lang, Dayne Beccano-Kelly, Jimena Baleriola, Nora Bengoa-Vergniory, Richard Wade-Martins
Understanding medium spiny neuron (MSN) physiology is essential to understand motor impairments in Parkinson's disease (PD) given the architecture of the basal ganglia. Here, we developed a custom three-chambered microfluidic platform and established a cortico-striato-nigral microcircuit partially recapitulating the striatal presynaptic landscape in vitro using induced pluripotent stem cell (iPSC)-derived neurons. We found that, cortical glutamatergic projections facilitated MSN synaptic activity, and dopaminergic transmission enhanced maturation of MSNs in vitro...
April 12, 2024: NPJ Parkinson's Disease
https://read.qxmd.com/read/38608828/convergence-of-oxytocin-and-dopamine-signaling-in-neuronal-circuits-insights-into-the-neurobiology-of-social-interactions-across-species
#22
REVIEW
Virginie Rappeneau, Fernando Castillo-Díaz
Social behaviours are essential for animal survival, and the hypothalamic neuropeptide oxytocin (OXT) critically impacts bonding, parenting, and decision-making. Dopamine (DA), is released by ventral tegmental area (VTA) dopaminergic neurons, regulating social cues in the mesolimbic system. Despite extensive exploration of OXT and DA roles in social behaviour independently, limited studies investigate their interplay. This narrative review integrates insights from human and animal studies, particularly rodents, emphasising recent research on pharmacological manipulations of OXT or DA systems in social behaviour...
April 10, 2024: Neuroscience and Biobehavioral Reviews
https://read.qxmd.com/read/38605179/the-classical-d1-dopamine-receptor-antagonist-sch23390-is-a-functional-sigma-1-receptor-allosteric-modulator
#23
JOURNAL ARTICLE
Gu-Fang Zhang, Kai-Lian Zhu, Qi Li, Yue Zhang, John L Waddington, Xiang-Dong Du, Xue-Chu Zhen
SCH23390 is a widely used D1 dopamine receptor (D1 R) antagonist that also elicits some D1 R-independent effects. We previously found that the benzazepine, SKF83959, an analog of SCH23390, produces positive allosteric modulation of the Sigma-1 receptor (Sig1R). SCH23390 does not bind to the orthodoxic site of Sig1R but enhances the binding of 3 H (+)-pentazocine to Sig1R. In this study, we investigated whether SCH23390 functions as an allosteric modulator of Sig1R. We detected increased Sig1R dissociation from binding immunoglobulin protein (BiP) and translocation of Sig1R to the plasma membrane in response to SCH23390 in transfected HEK293T and SH-SY5Y cells, respectively...
April 11, 2024: Acta Pharmacologica Sinica
https://read.qxmd.com/read/38602861/transdermal-delivery-of-pramipexole-using-microneedle-technology-for-the-potential-treatment-of-parkinson-s-disease
#24
JOURNAL ARTICLE
Mary B McGuckin, Aaron R J Hutton, Ellie R Davis, Akmal H B Sabri, Anastasia Ripolin, Achmad Himawan, Yara A Naser, Rand Ghanma, Brett Greer, Helen O McCarthy, Alejandro J Paredes, Eneko Larrañeta, Ryan F Donnelly
Parkinson's disease (PD) is a debilitating neurodegenerative disease primarily impacting neurons responsible for dopamine production within the brain. Pramipexole (PRA) is a dopamine agonist that is currently available in tablet form. However, individuals with PD commonly encounter difficulties with swallowing and gastrointestinal motility, making oral formulations less preferable. Microneedle (MN) patches represent innovative transdermal drug delivery devices capable of enhancing skin permeability through the creation of microconduits on the surface of the skin...
April 11, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38601010/functionalized-lipid-nanoparticles-modulate-the-blood-brain-barrier-and-eliminate-%C3%AE-synuclein-to-repair-dopamine-neurons
#25
JOURNAL ARTICLE
Xiaomei Wu, Renxiang Yuan, Yichong Xu, Kai Wang, Hong Yuan, Tingting Meng, Fuqiang Hu
The challenge in the clinical treatment of Parkinson's disease lies in the lack of disease-modifying therapies that can halt or slow down the progression. Peptide drugs, such as exenatide (Exe), with potential disease-modifying efficacy, have difficulty in crossing the blood-brain barrier (BBB) due to their large molecular weight. Herein, we fabricate multi-functionalized lipid nanoparticles (LNP) Lpc-BoSA/CSO with BBB targeting, permeability-increasing and responsive release functions. Borneol is chemically bonded with stearic acid and, as one of the components of Lpc-BoSA/CSO, is used to increase BBB permeability...
April 2024: Asian journal of pharmaceutical sciences
https://read.qxmd.com/read/38600154/am6527-a-neutral-cb1-receptor-antagonist-suppresses-opioid-taking-and-seeking-as-well-as-cocaine-seeking-in-rodents-without-aversive-effects
#26
JOURNAL ARTICLE
Omar Soler-Cedeño, Hannah Alton, Guo-Hua Bi, Emily Linz, Lipin Ji, Alexandros Makriyannis, Zheng-Xiong Xi
Preclinical research has demonstrated the efficacy of CB1 receptor (CB1R) antagonists in reducing drug-taking behavior. However, clinical trials with rimonabant, a CB1R antagonist with inverse agonist profile, failed due to severe adverse effects, such as depression and suicidality. As a result, efforts have shifted towards developing novel neutral CB1R antagonists without an inverse agonist profile for treating substance use disorders. Here, we assessed AM6527, a CB1R neutral antagonist, in addiction animal models...
April 10, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38599683/metabolic-sensing-in-agrp-regulates-sucrose-preference-and-dopamine-release-in-the-nucleus-accumbens
#27
JOURNAL ARTICLE
Alex Reichenbach, Harry Dempsey, Zane B Andrews
Hunger increases the motivation for calorie consumption, often at the expense of low-taste appeal. However, the neural mechanisms integrating calorie-sensing with increased motivation for calorie consumption remain unknown. Agouti-related peptide (AgRP) neurons in the arcuate nucleus of the hypothalamus sense hunger, and the ingestion of caloric solutions promotes dopamine release in the absence of sweet taste perception. Therefore, we hypothesised that metabolic-sensing of hunger by AgRP neurons would be essential to promote dopamine release in the nucleus accumbens in response to caloric, but not non-caloric solutions...
April 10, 2024: Journal of Neuroendocrinology
https://read.qxmd.com/read/38599494/glp-1-modulated-the-firing-activity-of-nigral-dopaminergic-neurons-in-both-normal-and-parkinsonian-mice
#28
JOURNAL ARTICLE
Cui Liu, Wen-Hong Liu, Wu Yang, Lei Chen, Yan Xue, Xin-Yi Chen
The spontaneous firing activity of nigral dopaminergic neurons is associated with some important roles including modulation of dopamine release, expression of tyrosine hydroxylase (TH), as well as neuronal survival. The decreased neuroactivity of nigral dopaminergic neurons has been revealed in Parkinson's disease. Central glucagon-like peptide-1 (GLP-1) functions as a neurotransmitter or neuromodulator to exert multiple brain functions. Although morphological studies revealed the expression of GLP-1 receptors (GLP-1Rs) in the substantia nigra pars compacta, the possible modulation of GLP-1 on spontaneous firing activity of nigral dopaminergic neurons is unknown...
April 8, 2024: Neuropharmacology
https://read.qxmd.com/read/38595283/dysfunction-of-synaptic-endocytic-trafficking-in-parkinson-s-disease
#29
JOURNAL ARTICLE
Xin Yi Ng, Mian Cao
Parkinson's disease is characterized by the selective degeneration of dopamine neurons in the nigrostriatal pathway and dopamine deficiency in the striatum. The precise reasons behind the specific degeneration of these dopamine neurons remain largely elusive. Genetic investigations have identified over 20 causative PARK genes and 90 genomic risk loci associated with both familial and sporadic Parkinson's disease. Notably, several of these genes are linked to the synaptic vesicle recycling process, particularly the clathrin-mediated endocytosis pathway...
December 1, 2024: Neural Regeneration Research
https://read.qxmd.com/read/38594619/targeting-mitochondrial-complex-i-deficiency-in-mpp-mptp-induced-parkinson-s-disease-cell-culture-and-mouse-models-by-transducing-yeast-ndi1-gene
#30
JOURNAL ARTICLE
Hongzhi Li, Jing Zhang, Yuqi Shen, Yifan Ye, Qingyou Jiang, Lan Chen, Bohao Sun, Zhuo Chen, Luxi Shen, Hezhi Fang, Jifeng Yang, Haihua Gu
BACKGROUND: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), original found in synthetic heroin, causes Parkinson's disease (PD) in human through its metabolite MPP+ by inhibiting complex I of mitochondrial respiratory chain in dopaminergic neurons. This study explored whether yeast internal NADH-quinone oxidoreductase (NDI1) has therapeutic effects in MPTP- induced PD models by functionally compensating for the impaired complex I. MPP+ -treated SH-SY5Y cells and MPTP-treated mice were used as the PD cell culture and mouse models respectively...
April 9, 2024: Biological Procedures Online
https://read.qxmd.com/read/38593008/dysfunctional-hippocampal-prefrontal-network-underlies-a-multidimensional-neuropsychiatric-phenotype-following-early-life-seizure
#31
JOURNAL ARTICLE
Rafael Naime Ruggiero, Danilo Benette Marques, Matheus Teixeira Rossignoli, Jana Batista De Ross, Tamiris Prizon, Ikaro Jesus Silva Beraldo, Lezio Soares Bueno-Junior, Ludmyla Kandratavicius, Jose Eduardo Peixoto-Santos, Cleiton Lopes-Aguiar, Joao Pereira Leite
Brain disturbances during development can have a lasting impact on neural function and behavior. Seizures during this critical period are linked to significant long-term consequences such as neurodevelopmental disorders, cognitive impairments, and psychiatric symptoms, resulting in a complex spectrum of multimorbidity. The hippocampus-prefrontal cortex (HPC-PFC) circuit emerges as a potential common link between such disorders. However, the mechanisms underlying these outcomes and how they relate to specific behavioral alterations are unclear...
April 9, 2024: ELife
https://read.qxmd.com/read/38588847/lesions-of-the-lateral-habenula-excite-dopamine-neurons-in-the-ventral-tegmental-area-and-serotonin-neurons-in-the-dorsal-raphe-nuclei-in-hemiparkinsonian-rats
#32
JOURNAL ARTICLE
Huihui Tan, Chengxue Du, Li Zhang, Yuan Guo, Yaxin Yang, Qingfeng Sun, Qiaojun Zhang, Libo Li
The lateral habenula (LHb) projects to the ventral tegmental area (VTA) and dorsal raphe nuclei (DRN) that deliver dopamine (DA) and serotonin (5-HT) to cortical and limbic regions such as the medial prefrontal cortex (mPFC), hippocampus and basolateral amygdala (BLA). Dysfunctions of VTA-related mesocorticolimbic dopaminergic and DRN-related serotonergic systems contribute to non-motor symptoms in Parkinson's disease (PD). However, how the LHb affects the VTA and DRN in PD remains unclear. Here, we used electrophysiological and neurochemical approaches to explore the effects of LHb lesions on the firing activity of VTA and DRN neurons, as well as the levels of DA and 5-HT in related brain regions in unilateral 6-ydroxydopamie (6-OHDA)-induced PD rats...
April 6, 2024: Brain Research
https://read.qxmd.com/read/38587883/transcriptomic-atlas-of-midbrain-dopamine-neurons-uncovers-differential-vulnerability-in-a-parkinsonism-lesion-model
#33
JOURNAL ARTICLE
Behzad Yaghmaeian Salmani, Laura Lahti, Linda Gillberg, Jesper Kjaer Jacobsen, Ioannis Mantas, Per Svenningsson, Thomas Perlmann
Midbrain dopamine (mDA) neurons comprise diverse cells with unique innervation targets and functions. This is illustrated by the selective sensitivity of mDA neurons of the substantia nigra compacta (SNc) in patients with Parkinson's disease, while those in the ventral tegmental area (VTA) are relatively spared. Here, we used single nuclei RNA sequencing (snRNA-seq) of approximately 70,000 mouse midbrain cells to build a high-resolution atlas of mouse mDA neuron diversity at the molecular level. The results showed that differences between mDA neuron groups could best be understood as a continuum without sharp differences between subtypes...
April 8, 2024: ELife
https://read.qxmd.com/read/38587319/a-novel-insight-into-the-neuroprotective-effects-of-cannabidiol-maintained-apelin-dopamine-synthesis-nrf2-signaling-and-akt-creb-bdnf-gene-expressions
#34
JOURNAL ARTICLE
Melike Doğan Ünlü, Sanem Aşçı, Orhan İmeci, Adem Milletsever, Özlem Özmen, Serdar Sezer, Serpil Demirci
Neuroinflammation is a process associated with degeneration and loss of neurons in different parts of the brain. The most important damage mechanisms in its formation are oxidative stress and inflammation. This study aimed to investigate the protective effects of cannabidiol (CBD) against neuroinflammation through various mechanisms. Thirty‑two female rats were randomly divided into 4 groups as control, lipopolysaccharide (LPS), LPS + CBD and CBD groups. After six hours following LPS administration, rats were sacrificed, brain and cerebellum tissues were obtained...
March 28, 2024: Acta Neurobiologiae Experimentalis
https://read.qxmd.com/read/38586193/the-impact-of-estradiol-on-serotonin-glutamate-and-dopamine-systems
#35
REVIEW
Peyton Christine Bendis, Sydney Zimmerman, Anna Onisiforou, Panos Zanos, Polymnia Georgiou
Estradiol, the most potent and prevalent member of the estrogen class of steroid hormones and is expressed in both sexes. Functioning as a neuroactive steroid, it plays a crucial role in modulating neurotransmitter systems affecting neuronal circuits and brain functions including learning and memory, reward and sexual behaviors. These neurotransmitter systems encompass the serotonergic, dopaminergic, and glutamatergic signaling pathways. Consequently, this review examines the pivotal role of estradiol and its receptors in the regulation of these neurotransmitter systems in the brain...
2024: Frontiers in Neuroscience
https://read.qxmd.com/read/38585864/prevalent-co-release-of-glutamate-and-gaba-throughout-the-mouse-brain
#36
Cesar C Ceballos, Lei Ma, Maozhen Qin, Haining Zhong
Several neuronal populations in the brain transmit both the excitatory and inhibitory neurotransmitters, glutamate, and GABA, to downstream neurons. However, it remains largely unknown whether these opposing neurotransmitters are co-released onto the same postsynaptic neuron simultaneously or are independently transmitted at different time and locations (called co-transmission). Here, using whole-cell patch-clamp recording on acute mouse brain slices, we observed biphasic miniature postsynaptic currents, i...
March 29, 2024: bioRxiv
https://read.qxmd.com/read/38585717/dopamine-neurons-drive-spatiotemporally-heterogeneous-striatal-dopamine-signals-during-learning
#37
Liv Engel, Amy R Wolff, Madelyn Blake, Val L Collins, Sonal Sinha, Benjamin T Saunders
Environmental cues, through Pavlovian learning, become conditioned stimuli that invigorate and guide animals toward acquisition of rewards. Dopamine neurons in the ventral tegmental area (VTA) and substantia nigra (SNC) are crucial for this process. Dopamine neurons are embedded in a reciprocally connected network with their striatal targets, the functional organization of which remains poorly understood. Here, we investigated how learning during optogenetic Pavlovian cue conditioning of VTA or SNC dopamine neurons directs cue-evoked behavior and shapes subregion-specific striatal dopamine dynamics...
March 30, 2024: bioRxiv
https://read.qxmd.com/read/38581677/distributional-coding-of-associative-learning-in-discrete-populations-of-midbrain-dopamine-neurons
#38
JOURNAL ARTICLE
Riccardo Avvisati, Anna-Kristin Kaufmann, Callum J Young, Gabriella E Portlock, Sophie Cancemi, Rui Ponte Costa, Peter J Magill, Paul D Dodson
Midbrain dopamine neurons are thought to play key roles in learning by conveying the difference between expected and actual outcomes. Recent evidence suggests diversity in dopamine signaling, yet it remains poorly understood how heterogeneous signals might be organized to facilitate the role of downstream circuits mediating distinct aspects of behavior. Here, we investigated the organizational logic of dopaminergic signaling by recording and labeling individual midbrain dopamine neurons during associative behavior...
April 4, 2024: Cell Reports
https://read.qxmd.com/read/38580194/midbrain-organoids-for-parkinson-s-disease-pd-a-powerful-tool-to-understand-the-disease-pathogenesis
#39
REVIEW
Harysh Winster Suresh Babu, Sindduja Muthu Kumar, Harsimrat Kaur, Mahalaxmi Iyer, Balachandar Vellingiri
Brain Organiods (BOs) are a promising technique for researching disease progression in the human brain. These organoids, which are produced from human induced pluripotent stem cells (HiPSCs), can construct themselves into structured frameworks. In the context of Parkinson's disease (PD), recent advancements have been made in the development of Midbrain organoids (MBOs) models that consider key pathophysiological mechanisms such as alpha-synuclein (α-Syn), Lewy bodies, dopamine loss, and microglia activation...
April 3, 2024: Life Sciences
https://read.qxmd.com/read/38580154/aging-hastens-locomotor-decline-in-pink1-knockout-rats-in-association-with-decreased-nigral-but-not-striatal-dopamine-and-tyrosine-hydroxylase-expression
#40
JOURNAL ARTICLE
Isabel Soto, Robert McManus, Walter Navarrete-Barahona, Ella A Kasanga, Kirby Doshier, Vicki A Nejtek, Michael F Salvatore
Parkinson's disease (PD) rodent models provide insight into the relationship between nigrostriatal dopamine (DA) signaling and locomotor function. Although toxin-based rat models produce frank nigrostriatal neuron loss and eventual motor decline characteristic of PD, the rapid nature of neuronal loss may not adequately translate premotor traits, such as cognitive decline. Unfortunately, rodent genetic PD models, like the Pink1 knockout (KO) rat, often fail to replicate the differential severity of striatal DA and tyrosine hydroxylase (TH) loss, and a bradykinetic phenotype, reminiscent of human PD...
April 3, 2024: Experimental Neurology
keyword
keyword
38986
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.